ABSTRACT
Objective: To investigate the regulatory role of HK2 in the metastasis of hepatocellular carcinoma (HCC). Methods: The protein expressions of HK2 in 73 HCC tumor tissues and paired adjacent non-tumor tissues were evaluated by using immunohistochemical analysis. The scratch wound healing assay and Transwell assay had been used to analyze the migration and invasion of HCC cells with HK2 knockdown. Expressions of epithelial-to-mesenchymal transition (EMT)markers, such as E-cadherin, ZO-1, N-cadherin and vimentin, in HCC cells with HK2 knockdown were determined by qRT-PCR and Western blot analysis. Results: The expression levels of HK2 in tumor tissues and adjacent non-tumor tissues were 5.39±3.40 and 2.16±1.55, respectively. The protein expression of HK2 was significantly higher in tumor tissues compared with adjacent non-tumor tissues of HCC (P<0.05). Knockdown of HK2 in HCC cells decreased the cell motility from 1.00±0.54 to 0.56±0.09 (P<0.05), andknockdown of HK2 in HCC cells decreased the number of invaded cells form 345±42 to 215±34 (P<0.05). The expression of epithelial markers ZO-1 and E-cadherin were up-regulated, while mesenchymal markers vimentin and N-cadherin were down-regulated in HCC cells when HK2 was knockeddown. Conclusions: HK2 is up-regulated in HCC and promotes cell motility by stimulating EMT.
Subject(s)
Carcinoma, Hepatocellular/secondary , Cell Movement , Hexokinase/metabolism , Liver Neoplasms/pathology , Neoplasm Proteins/metabolism , Antigens, CD/metabolism , Cadherins/metabolism , Carcinoma, Hepatocellular/enzymology , Down-Regulation , Epithelial-Mesenchymal Transition , Gene Knockdown Techniques , Hexokinase/genetics , Humans , Liver Neoplasms/enzymology , Neoplasm Invasiveness , Neoplasm Proteins/genetics , Up-Regulation , Vimentin/metabolism , Zonula Occludens-1 Protein/metabolismABSTRACT
Degenerative osteoarthropathy, a kind of arthrosis induced by various factors, mainly affects articular cartilage and causes syndesmophyte formation. Its morbidity increases year by year, tending to occur more among young people than previously. This paper mainly discusses the clinical effects of iontophoresis of the Chinese drug in treating degenerative osteoarthropathy. A total of 296 cases of degenerative osteoarthropathy were randomly divided into two groups (of both genders): the iontophoresis group: the joint was treated with iontophoresis of the Chinese drug and a medium frequency electrotherapy instrument; the frequency electrotherapy group: the joint was treated only by medium frequency electrotherapy. The two groups were both treated for 30 min once a day, for a total of 4 weeks. The results of the study showed that, the total effective rate in the medium frequency electrotherapy group was 74.3%, the iontophoresis group was 93.2%, indicating the curative effect of iontophoresis of the Chinese medicine. The above finding indicates that, iontophoresis has a good clinical effect in the treatment of osteoarthropathy and deserves to be promoted and applied.
Subject(s)
Drugs, Chinese Herbal/therapeutic use , Iontophoresis/methods , Osteoarthritis/therapy , Drugs, Chinese Herbal/administration & dosage , Electric Stimulation Therapy/methods , Humans , Joints/physiology , Osteoarthritis/drug therapy , Pain Measurement , Treatment OutcomeABSTRACT
BACKGROUND: Fibrin sealant is frequently used in knee surgery as an adjuvant method for reducing postoperative bleeding, however, there is no consensus regarding the efficacy of fibrin sealant. HYPOTHESIS: Fibrin sealant achieves better efficacy in terms of blood loss control, transfusion rate and units in knee surgery compared with controls. METHODS: A search of the Cochrane Collaboration (2013 Issue 09), Embase (1974-2013.09), PubMed (1966-2013.09) and Chinese databases (up to 2013.09) were conducted. The Cochrane Collaboration's tool was used to assess for bias and data were analyzed by RevMan 5.29 software. RESULTS: This study included nine RCTs and four prospective comparative trials with a total of 1299 patients. Compared to the control, fibrin sealant achieved a decrease in hemoglobin reduction [MD=1.14, 95% CI (0.61-1.67)], transfusion rate [OR=0.36, 95% CI (0.25-0.51)], transfusion units [MD=0.47, 95% CI (0.24-0.71)], hospital stay [MD=2.22, 95% CI (0.56-3.88)] and the incidence of complications [OR=0.56, 95% CI (0.38-0.83)]. And it also reduced total blood loss, while there was no significant difference [MD=155.83, 95% CI (-525.02-213.15)]. CONCLUSION: Patients undergoing knee surgery would benefit from high-dose fibrin sealant with reduced transfusion rate and unit, hospital stay and complications, while they might benefit little from it in total blood loss. However, the effects of a low-dose of fibrin in knee surgery remain inconclusive.